These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28391779)

  • 1. Tusc2/Fus1 regulates osteoclast differentiation through NF-κB and NFATc1.
    Kim I; Kim JH; Kim K; Seong S; Kim N
    BMB Rep; 2017 Sep; 50(9):454-459. PubMed ID: 28391779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
    Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
    BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB.
    Kim WS; Kim HJ; Lee ZH; Lee Y; Kim HH
    Exp Cell Res; 2013 Feb; 319(4):436-46. PubMed ID: 23246654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT.
    Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-binding protein Musashi2 induced by RANKL is critical for osteoclast survival.
    Fujiwara T; Zhou J; Ye S; Zhao H
    Cell Death Dis; 2016 Jul; 7(7):e2300. PubMed ID: 27441652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pim-1 regulates RANKL-induced osteoclastogenesis via NF-κB activation and NFATc1 induction.
    Kim K; Kim JH; Youn BU; Jin HM; Kim N
    J Immunol; 2010 Dec; 185(12):7460-6. PubMed ID: 21068407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB.
    Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K
    Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation.
    Sundaram K; Nishimura R; Senn J; Youssef RF; London SD; Reddy SV
    Exp Cell Res; 2007 Jan; 313(1):168-78. PubMed ID: 17084841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATF3 modulates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins.
    Jeong BC; Kim JH; Kim K; Kim I; Seong S; Kim N
    Bone; 2017 Feb; 95():33-40. PubMed ID: 27829167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts.
    Komarova SV; Pereverzev A; Shum JW; Sims SM; Dixon SJ
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2643-8. PubMed ID: 15695591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways.
    Zhou L; Song F; Liu Q; Yang M; Zhao J; Tan R; Xu J; Zhang G; Quinn JM; Tickner J; Xu J
    Int J Mol Sci; 2015 Nov; 16(11):27087-96. PubMed ID: 26580592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway.
    Cong F; Liu J; Wang C; Yuan Z; Bi L; Liang J; Su K; Qiu Y; Song T; Fan J; Chao G
    Biomed Pharmacother; 2017 Aug; 92():927-934. PubMed ID: 28605877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation.
    Yang S; Li YP
    Genes Dev; 2007 Jul; 21(14):1803-16. PubMed ID: 17626792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclast differentiation by RANKL requires NF-kappaB-mediated downregulation of cyclin-dependent kinase 6 (Cdk6).
    Ogasawara T; Katagiri M; Yamamoto A; Hoshi K; Takato T; Nakamura K; Tanaka S; Okayama H; Kawaguchi H
    J Bone Miner Res; 2004 Jul; 19(7):1128-36. PubMed ID: 15176996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTORC1 Inhibits NF-κB/NFATc1 Signaling and Prevents Osteoclast Precursor Differentiation, In Vitro and In Mice.
    Zhang Y; Xu S; Li K; Tan K; Liang K; Wang J; Shen J; Zou W; Hu L; Cai D; Ding C; Li M; Xiao G; Liu B; Liu A; Bai X
    J Bone Miner Res; 2017 Sep; 32(9):1829-1840. PubMed ID: 28520214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM38 regulates NF-κB activation through TAB2 degradation in osteoclast and osteoblast differentiation.
    Kim K; Kim JH; Kim I; Seong S; Kim N
    Bone; 2018 Aug; 113():17-28. PubMed ID: 29753717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility.
    Jin SH; Kim H; Gu DR; Park KH; Lee YR; Choi Y; Lee SH
    BMB Rep; 2018 Jul; 51(7):356-361. PubMed ID: 29921413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RANKL induces NFATc1 acetylation and stability via histone acetyltransferases during osteoclast differentiation.
    Kim JH; Kim K; Youn BU; Jin HM; Kim JY; Moon JB; Ko A; Seo SB; Lee KY; Kim N
    Biochem J; 2011 Jun; 436(2):253-62. PubMed ID: 21413932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.